BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 2017

View Archived Issues

Biocon launches bevacizumab biosimilar Krabeva in India

Read More

Plasmepsins IX and X as promising new dual targets for malaria eradication

Read More

Data show encouraging activity with BMS-986205 plus nivolumab in phase I/II study

Read More

Researchers describe novel potent peptidic inhibitors of influenza hemagglutinin

Read More

Chemo group changes its name to Insud Pharma

Read More

Novel IDO-1 inhibitors discovered at GlaxoSmithKline

Read More

University of Minnesota patents new monocarboxylate transporter 1/4 inhibitors

Read More

Inflection Biosciences and RCSI collaborate to understand mechanisms of resistance in breast cancer

Read More

University of Michigan presents histone-lysine N-methyltransferase ASH1L inhibitors

Read More

Vanc set to launch INSTI HIV rapid point-of-care test

Read More

MA-0217 as a promising new agent for ischemic acute kidney injury

Read More

Novel antiparasitic compounds synthesized at Anacor

Read More

Jubilant Biosys describes new dual KDM1A/HDAC inhibitors

Read More

Pharming submits sBLA for Ruconest for prevention of HAE attacks

Read More

AstraZeneca seeks Japanese approval for Tagrisso in first-line EGFR-mutated NSCLC

Read More

Genfit contributes to LITMUS European consortium in NAFLD

Read More

AstraZeneca and Chinese FIIF to establish joint venture in China

Read More

Phase III study finds significant ON time improvement with sublingual apomorphine film

Read More

Immungenetics initiates DrainAD phase II study of thiethylperazine for the treatment of AD

Read More

VS-605, a novel highly effective phosphate binder

Read More

HitGen and Boehringer Ingelheim establish drug discovery research collaboration

Read More

Symphogen opens phase I study of Sym-021 in advanced solid tumor malignancies or lymphomas

Read More

Phase II results for nesvacumab and aflibercept combination therapy do not warrant progression

Read More

New study explores BOLT with BMT in primary immunodeficiency patients with end-stage lung disease

Read More

Merck Sharp & Dohme initiates phase I study of MK-7252 in healthy subjects

Read More

Japanese approval sought for DE-117 for glaucoma and ocular hypertension

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing